Basis: Trailing twelve months (TTM), to the latest fiscal quarter end. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the return on invested capital (ROIC) high or low?
The return on invested capital (ROIC) of -54.07% is 43% below its 5-year average of -37.71%, near the low end of its 5-year range (-75.52%–20.05%).
As of the fiscal period ended Tuesday, June 30, 2026. 44.02% below its 12-month average of -37.54%.
Trailing-twelve-month return on invested capital at each fiscal quarter end; no daily interpolation. Q2 FY2026 (2026-06-30): -54.07%.
RETURN ON INVESTED CAPITAL (ROIC)
-54.07%
RETURN ON INVESTED CAPITAL (ROIC) AVG TTM
-37.54%
RETURN ON INVESTED CAPITAL (ROIC) AVG 3Y
-31.66%
RETURN ON INVESTED CAPITAL (ROIC) AVG 5Y
-37.71%
RETURN ON INVESTED CAPITAL (ROIC) AVG 10Y
-41.26%
RETURN ON INVESTED CAPITAL (ROIC) AVG 15Y
N/A
RETURN ON INVESTED CAPITAL (ROIC) AVG 20Y
N/A
CURRENT VS TTM AVG
-44.02%
CURRENT VS 3Y AVG
-70.78%
CURRENT VS 5Y AVG
-43.35%
CURRENT VS 10Y AVG
-31.03%
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
-34.78%
median of 596 covered companies
CURRENT VS SECTOR MEDIAN
-55.45%
vs the sector median at left
Arcturus Therapeutics Holdings Inc.
Market Cap
$377.66M
Return on Invested Capital (ROIC)
-54.07%
TTM Avg
-37.54%
3Y Avg
-31.66%
5Y Avg
-37.71%
Market Cap
$378.64M
Return on Invested Capital (ROIC)
-80.67%
TTM Avg
-59.31%
3Y Avg
-71.22%
5Y Avg
-64.55%
Market Cap
$381.71M
Return on Invested Capital (ROIC)
-69.35%
TTM Avg
-52.27%
3Y Avg
-73.46%
5Y Avg
-73.46%
Market Cap
$383.33M
Return on Invested Capital (ROIC)
-3.55%
TTM Avg
-10.84%
3Y Avg
-10.87%
5Y Avg
-7.87%
Market Cap
$370.48M
Return on Invested Capital (ROIC)
-10.85%
TTM Avg
-10.82%
3Y Avg
-40.29%
5Y Avg
-33.17%
Market Cap
$354.49M
Return on Invested Capital (ROIC)
-56.73%
TTM Avg
-80.02%
3Y Avg
-65.94%
5Y Avg
-165.76%
Market Cap
$357.76M
Return on Invested Capital (ROIC)
-93.74%
TTM Avg
-188.84%
3Y Avg
-156.74%
5Y Avg
-129.07%
Market Cap
$355.08M
Return on Invested Capital (ROIC)
17.99%
TTM Avg
23.20%
3Y Avg
26.35%
5Y Avg
40.47%
Market Cap
$401.40M
Return on Invested Capital (ROIC)
-19.13%
TTM Avg
-11.02%
3Y Avg
-12.07%
5Y Avg
-13.96%
| NAME | MARKET CAP | RETURN ON INVESTED CAPITAL (ROIC) | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Arcturus Therapeutics Holdings Inc. (ARCT) | $377.66M | -54.07% | -37.54% | -31.66% | -37.71% |
| Kyverna Therapeutics, Inc. (KYTX)vs › | $378.64M | -80.67% | -59.31% | -71.22% | -64.55% |
| MapLight Therapeutics, Inc. (MPLT)vs › | $381.71M | -69.35% | -52.27% | -73.46% | -73.46% |
| Orthofix Medical Inc. (OFIX)vs › | $383.33M | -3.55% | -10.84% | -10.87% | -7.87% |
| Canopy Growth Corporation (CGC)vs › | $370.48M | -10.85% | -10.82% | -40.29% | -33.17% |
| Orchestra BioMed Holdings, Inc. (OBIO)vs › | $354.49M | -56.73% | -80.02% | -65.94% | -165.76% |
| Ocugen, Inc. (OCGN)vs › | $357.76M | -93.74% | -188.84% | -156.74% | -129.07% |
| Embecta Corp. (EMBC)vs › | $355.08M | 17.99% | 23.20% | 26.35% | 40.47% |
| Myriad Genetics, Inc. (MYGN)vs › | $401.40M | -19.13% | -11.02% | -12.07% | -13.96% |
| Fennec Pharmaceuticals Inc. (FENC)vs › | $353.28M | -1.84% | -2.07% | -43.39% | -53.01% |
ROIC
-54.1%
ROE
-54.3%
ROIC = NOPAT / Invested Capital, where NOPAT = Operating Income × (1 − effective tax rate) and Invested Capital = Total Assets − (Current Liabilities − Short-Term Debt)
Return on invested capital measures the after-tax operating return a company earns on the capital invested in the business. TGMCharts computes it from reported statements: trailing-twelve-month operating income after tax, over invested capital at the latest balance sheet — total assets less the non-interest-bearing current liabilities (payables, accruals, deferred revenue) that fund them; short-term debt stays in the capital base. The tax rate is the period's own effective rate (income tax ÷ pretax income), capped at 45%; when pretax income is zero or negative, or the tax line is a net benefit, no tax is deducted — the operating figure is shown untaxed rather than adjusted by an assumed rate. Not shown for banks, insurers or funds.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | RETURN ON INVESTED CAPITAL (ROIC) |
|---|---|
| 2026-06-30 | -54.07% |
| 2026-03-31 | -42.27% |
| 2025-12-31 | -32.48% |
| 2025-09-30 | -31.26% |
| 2025-06-30 | -27.62% |
| 2025-03-31 | -29.07% |
| 2024-12-31 | -34.34% |
| 2024-09-30 | -26.74% |
| 2024-06-30 | -29.63% |
| 2024-03-31 | -40.66% |
| 2023-12-31 | -22.51% |
| 2023-09-30 | 16.16% |
| 2023-06-30 | 12.63% |
| 2023-03-31 | 20.05% |
| 2022-12-31 | 2.78% |
| 2022-09-30 | -59.85% |
| 2022-06-30 | -60.43% |
| 2022-03-31 | -75.52% |
| 2021-12-31 | -64.24% |
| 2021-09-30 | -58.63% |
| 2021-06-30 | -42.66% |
| 2021-03-31 | -27.76% |
| 2020-12-31 | -16.70% |
| 2020-09-30 | -17.41% |
| 2020-06-30 | -29.90% |
| 2020-03-31 | -56.42% |
| 2019-12-31 | -41.95% |
| 2019-09-30 | -23.51% |
| 2019-06-30 | -22.28% |
| 2019-03-31 | -72.62% |
| 2018-12-31 | -68.98% |
| 2018-09-30 | -90.34% |
| 2018-06-30 | -75.88% |
| 2017-12-31 | -25.60% |
| 2017-09-30 | -42.94% |
| 2017-06-30 | -52.77% |
| 2017-03-31 | -53.29% |
| 2016-12-31 | -53.14% |
| 2016-09-30 | -45.70% |
| 2016-06-30 | -34.20% |
| 2016-03-31 | -30.32% |
| 2015-12-31 | -28.41% |
| 2015-09-30 | -61.43% |
| 2015-06-30 | -71.76% |
| 2014-12-31 | -165.86% |
| 2014-09-30 | -122.87% |
| 2014-06-30 | -69.02% |
| 2014-03-31 | -42.15% |
| 2013-12-31 | -21.13% |
| 2013-09-30 | -26.43% |
| 2013-06-30 | -9.47% |
